Antonio Grieco
Antonio Grieco
Professore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, Roma
Email verificata su rm.unicatt.it
TitoloCitata daAnno
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ...
Hepatology 49 (6), 1877-1887, 2009
9792009
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
G Fattovich, G Giustina, S Favarato, A Ruol
Journal of hepatology 24 (1), 38-47, 1996
6011996
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia
M Venditti, M Falcone, S Corrao, G Licata, P Serra
Annals of internal medicine 150 (1), 19, 2009
3102009
Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy
M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ...
Hepatology 54 (6), 2055-2063, 2011
3042011
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging …
A Grieco, M Pompili, G Caminiti, L Miele, M Covino, B Alfei, GL Rapaccini, ...
Gut 54 (3), 411-418, 2005
2892005
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ...
Digestive and Liver Disease 47 (12), 997-1006, 2015
2202015
The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota
ML Balmer, E Slack, A De Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ...
Science translational medicine 6 (237), 237ra66-237ra66, 2014
2092014
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease
L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ...
Gastroenterology 135 (1), 282-291. e1, 2008
1752008
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial
C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ...
Free Radical Biology and Medicine 52 (9), 1658-1665, 2012
1742012
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
L Miele, S Vallone, C Cefalo, G La Torre, C Di Stasi, FM Vecchio, ...
Journal of hepatology 51 (4), 778-786, 2009
1702009
High efficacy of 1‐week doxycycline‐and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection
G Cammarota, A Martino, G Pirozzi, R Cianci, G Branca, EC Nista, ...
Alimentary pharmacology & therapeutics 19 (7), 789-795, 2004
1372004
Breath testing for human liver function assessment
A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, ...
Alimentary pharmacology & therapeutics 16 (12), 1977-1996, 2002
1242002
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test
L Miele, A Grieco, A Armuzzi, M Candelli, A Forgione, A Gasbarrini, ...
The American journal of gastroenterology 98 (10), 2335, 2003
1062003
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ...
Digestive and Liver Disease 46 (6), 556-560, 2014
912014
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
AL Fracanzani, L Valenti, E Bugianesi, E Vanni, A Grieco, L Miele, ...
Journal of hepatology 54 (6), 1244-1249, 2011
852011
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review
M Pompili, M Biolato, L Miele, A Grieco
World journal of gastroenterology: WJG 19 (44), 7867, 2013
842013
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target
L Miele, G Marrone, C Lauritano, C Cefalo, A Gasbarrini, C Day, A Grieco
Current pharmaceutical design 19 (29), 5314-5324, 2013
812013
Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
C Cammà, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ...
Hepatology 57 (3), 1046-1054, 2013
802013
Fatty liver and drugs
A Grieco, A Forgione, L Miele, V Vero, AV Greco, A Gasbarrini, ...
European review for medical and pharmacological sciences 9 (5), 261, 2005
802005
Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk
L Miele, V Giorgio, MA Alberelli, E De Candia, A Gasbarrini, A Grieco
Current cardiology reports 17 (12), 120, 2015
762015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20